Contribution of cytochrome P450 4A isoforms to renal functional response to inhibition of nitric oxide production in the rat

Hantz C. Hercule, Mong-Heng Wang, Adebayo O. Oyekan

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

20-Hydroxyeicosatetraenoic acid (20-HETE), a major renal eicosanoid, regulates renal function and contributes to renal responses following withdrawal of nitric oxide (NO). However, the role of 20-HETE-synthesizing isoforms in renal function resulting from NO inhibition is unknown. The present study evaluated the role of cytochrome (CYP)4A1, -4A2 and -4A3 isoforms on renal function in the presence and absence of NO. Antisense oligonucleotides (ASODN) to CYP4A1, -4A2 and -4A3 reduced 20-HETE synthesis and downregulated the expression of CYP4A isoforms in renal microsomes. Nω-L-nitromethyl arginine ester (L-NAME, 25 mg kg-1), an inhibitor of NO production, increased mean arterial blood pressure (MABP, Δ = +18 to 26 mmHg), reduced renal blood flow (RBF, Δ = -1.8 to 2.9 ml min-1 , increased renal vascular resistance (RVR, Δ = +47 to 54 mmHg ml-1 min-1), reduced glomerular filtration rate (GFR), but increased sodium excretion (UNaV). ASODN to CYP4A1 and -4A2 but not -4A3 reduced basal MABPand RVR and increased basal GFR, while ASODN to CYP4A2 significantly reduced basal UNaV suggesting a differential role for CYP4A isoforms in the regulation of renal function. ASODN to CYP4A2 but not -4A1 or -4A3 blunted the increase in MABP by L-NAME (38 ± 9 %, P < 0.05). ASODN to CYP4A1, -4A2 and -4A3 attenuated the reduction in RBF and the consequent increase in RVR by L-NAME with a potency order of CYP4A2 = CYP4A1 > CYP4A3. ASODN to CYP4A1 and -4A2 but not -4A3 attenuated L-NAME-induced reduction in GFR, but ASODN to all three CYP4A isoforms blunted the L-NAME-induced increase in UNaV (CYP4A3 > CYP4A1 >> CYP4A2). We conclude from these data that CYP4A isoforms contribute to different extents to basal renal function. Moreover, CYP4A2 contributes greatest to haemodynamic responses while CYP4A3 contributes greatest to tubular responses following NO inhibition. We therefore propose that NO differentially regulates the function of CYP4A1, -4A2, and -4A3 isoforms in the renal vasculature and the nephron.

Original languageEnglish (US)
Pages (from-to)971-979
Number of pages9
JournalJournal of Physiology
Volume551
Issue number3
DOIs
StatePublished - Sep 15 2003
Externally publishedYes

Fingerprint

Cytochrome P-450 Enzyme System
Nitric Oxide
Protein Isoforms
Kidney
Cytochrome P-450 CYP4A
NG-Nitroarginine Methyl Ester
Glomerular Filtration Rate
Arterial Pressure
Eicosanoids
Antisense Oligonucleotides
Renal Circulation
Nephrons
Cytochromes
Microsomes
Vascular Resistance
Arginine
Esters
Down-Regulation
Hemodynamics
Sodium

ASJC Scopus subject areas

  • Physiology

Cite this

Contribution of cytochrome P450 4A isoforms to renal functional response to inhibition of nitric oxide production in the rat. / Hercule, Hantz C.; Wang, Mong-Heng; Oyekan, Adebayo O.

In: Journal of Physiology, Vol. 551, No. 3, 15.09.2003, p. 971-979.

Research output: Contribution to journalArticle

@article{f42d42b7dc524ee48ade31812400a79e,
title = "Contribution of cytochrome P450 4A isoforms to renal functional response to inhibition of nitric oxide production in the rat",
abstract = "20-Hydroxyeicosatetraenoic acid (20-HETE), a major renal eicosanoid, regulates renal function and contributes to renal responses following withdrawal of nitric oxide (NO). However, the role of 20-HETE-synthesizing isoforms in renal function resulting from NO inhibition is unknown. The present study evaluated the role of cytochrome (CYP)4A1, -4A2 and -4A3 isoforms on renal function in the presence and absence of NO. Antisense oligonucleotides (ASODN) to CYP4A1, -4A2 and -4A3 reduced 20-HETE synthesis and downregulated the expression of CYP4A isoforms in renal microsomes. Nω-L-nitromethyl arginine ester (L-NAME, 25 mg kg-1), an inhibitor of NO production, increased mean arterial blood pressure (MABP, Δ = +18 to 26 mmHg), reduced renal blood flow (RBF, Δ = -1.8 to 2.9 ml min-1 , increased renal vascular resistance (RVR, Δ = +47 to 54 mmHg ml-1 min-1), reduced glomerular filtration rate (GFR), but increased sodium excretion (UNaV). ASODN to CYP4A1 and -4A2 but not -4A3 reduced basal MABPand RVR and increased basal GFR, while ASODN to CYP4A2 significantly reduced basal UNaV suggesting a differential role for CYP4A isoforms in the regulation of renal function. ASODN to CYP4A2 but not -4A1 or -4A3 blunted the increase in MABP by L-NAME (38 ± 9 {\%}, P < 0.05). ASODN to CYP4A1, -4A2 and -4A3 attenuated the reduction in RBF and the consequent increase in RVR by L-NAME with a potency order of CYP4A2 = CYP4A1 > CYP4A3. ASODN to CYP4A1 and -4A2 but not -4A3 attenuated L-NAME-induced reduction in GFR, but ASODN to all three CYP4A isoforms blunted the L-NAME-induced increase in UNaV (CYP4A3 > CYP4A1 >> CYP4A2). We conclude from these data that CYP4A isoforms contribute to different extents to basal renal function. Moreover, CYP4A2 contributes greatest to haemodynamic responses while CYP4A3 contributes greatest to tubular responses following NO inhibition. We therefore propose that NO differentially regulates the function of CYP4A1, -4A2, and -4A3 isoforms in the renal vasculature and the nephron.",
author = "Hercule, {Hantz C.} and Mong-Heng Wang and Oyekan, {Adebayo O.}",
year = "2003",
month = "9",
day = "15",
doi = "10.1113/jphysiol.2003.049981",
language = "English (US)",
volume = "551",
pages = "971--979",
journal = "Journal of Physiology",
issn = "0022-3751",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Contribution of cytochrome P450 4A isoforms to renal functional response to inhibition of nitric oxide production in the rat

AU - Hercule, Hantz C.

AU - Wang, Mong-Heng

AU - Oyekan, Adebayo O.

PY - 2003/9/15

Y1 - 2003/9/15

N2 - 20-Hydroxyeicosatetraenoic acid (20-HETE), a major renal eicosanoid, regulates renal function and contributes to renal responses following withdrawal of nitric oxide (NO). However, the role of 20-HETE-synthesizing isoforms in renal function resulting from NO inhibition is unknown. The present study evaluated the role of cytochrome (CYP)4A1, -4A2 and -4A3 isoforms on renal function in the presence and absence of NO. Antisense oligonucleotides (ASODN) to CYP4A1, -4A2 and -4A3 reduced 20-HETE synthesis and downregulated the expression of CYP4A isoforms in renal microsomes. Nω-L-nitromethyl arginine ester (L-NAME, 25 mg kg-1), an inhibitor of NO production, increased mean arterial blood pressure (MABP, Δ = +18 to 26 mmHg), reduced renal blood flow (RBF, Δ = -1.8 to 2.9 ml min-1 , increased renal vascular resistance (RVR, Δ = +47 to 54 mmHg ml-1 min-1), reduced glomerular filtration rate (GFR), but increased sodium excretion (UNaV). ASODN to CYP4A1 and -4A2 but not -4A3 reduced basal MABPand RVR and increased basal GFR, while ASODN to CYP4A2 significantly reduced basal UNaV suggesting a differential role for CYP4A isoforms in the regulation of renal function. ASODN to CYP4A2 but not -4A1 or -4A3 blunted the increase in MABP by L-NAME (38 ± 9 %, P < 0.05). ASODN to CYP4A1, -4A2 and -4A3 attenuated the reduction in RBF and the consequent increase in RVR by L-NAME with a potency order of CYP4A2 = CYP4A1 > CYP4A3. ASODN to CYP4A1 and -4A2 but not -4A3 attenuated L-NAME-induced reduction in GFR, but ASODN to all three CYP4A isoforms blunted the L-NAME-induced increase in UNaV (CYP4A3 > CYP4A1 >> CYP4A2). We conclude from these data that CYP4A isoforms contribute to different extents to basal renal function. Moreover, CYP4A2 contributes greatest to haemodynamic responses while CYP4A3 contributes greatest to tubular responses following NO inhibition. We therefore propose that NO differentially regulates the function of CYP4A1, -4A2, and -4A3 isoforms in the renal vasculature and the nephron.

AB - 20-Hydroxyeicosatetraenoic acid (20-HETE), a major renal eicosanoid, regulates renal function and contributes to renal responses following withdrawal of nitric oxide (NO). However, the role of 20-HETE-synthesizing isoforms in renal function resulting from NO inhibition is unknown. The present study evaluated the role of cytochrome (CYP)4A1, -4A2 and -4A3 isoforms on renal function in the presence and absence of NO. Antisense oligonucleotides (ASODN) to CYP4A1, -4A2 and -4A3 reduced 20-HETE synthesis and downregulated the expression of CYP4A isoforms in renal microsomes. Nω-L-nitromethyl arginine ester (L-NAME, 25 mg kg-1), an inhibitor of NO production, increased mean arterial blood pressure (MABP, Δ = +18 to 26 mmHg), reduced renal blood flow (RBF, Δ = -1.8 to 2.9 ml min-1 , increased renal vascular resistance (RVR, Δ = +47 to 54 mmHg ml-1 min-1), reduced glomerular filtration rate (GFR), but increased sodium excretion (UNaV). ASODN to CYP4A1 and -4A2 but not -4A3 reduced basal MABPand RVR and increased basal GFR, while ASODN to CYP4A2 significantly reduced basal UNaV suggesting a differential role for CYP4A isoforms in the regulation of renal function. ASODN to CYP4A2 but not -4A1 or -4A3 blunted the increase in MABP by L-NAME (38 ± 9 %, P < 0.05). ASODN to CYP4A1, -4A2 and -4A3 attenuated the reduction in RBF and the consequent increase in RVR by L-NAME with a potency order of CYP4A2 = CYP4A1 > CYP4A3. ASODN to CYP4A1 and -4A2 but not -4A3 attenuated L-NAME-induced reduction in GFR, but ASODN to all three CYP4A isoforms blunted the L-NAME-induced increase in UNaV (CYP4A3 > CYP4A1 >> CYP4A2). We conclude from these data that CYP4A isoforms contribute to different extents to basal renal function. Moreover, CYP4A2 contributes greatest to haemodynamic responses while CYP4A3 contributes greatest to tubular responses following NO inhibition. We therefore propose that NO differentially regulates the function of CYP4A1, -4A2, and -4A3 isoforms in the renal vasculature and the nephron.

UR - http://www.scopus.com/inward/record.url?scp=0141535335&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141535335&partnerID=8YFLogxK

U2 - 10.1113/jphysiol.2003.049981

DO - 10.1113/jphysiol.2003.049981

M3 - Article

C2 - 12857783

AN - SCOPUS:0141535335

VL - 551

SP - 971

EP - 979

JO - Journal of Physiology

JF - Journal of Physiology

SN - 0022-3751

IS - 3

ER -